Oasis Tears PF Eye Drops Recall Issued for Sterility Concerns
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Oasis Medical, Inc. is voluntarily recalling specific lots of Oasis Tears PF preservative-free lubricant eye drops nationwide due to lack of assurance of sterility.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on June 2, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, eye-drops.
What Happened
Oasis Medical, Inc. initiated a voluntary recall of Oasis Tears PF eye drops out of an abundance of caution following FDA observations during a recent inspection of Excelvision. The recall is classified as Class II.
Which Products Are Affected
- Product: Oasis Tears PF, Preservative-Free Lubricant Eye Drops, 10mL/0.34 Fl OZ Bottle, Sterile
- NDC: 42126-6400-1
- Lots: #1V59 (Exp: 05/31/26); #3V12 and #3V69 (Exp: 08/31/26)
- Distribution: Nationwide within the United States
- Recall Number: D-0525-2026
What You Should Do
Consumers should stop using the affected product. Contact information for returns or further guidance is available from the recalling firm, Oasis Medical, Inc.
Why This Matters
This Class II recall addresses a potential lack of sterility assurance for an ophthalmic product distributed nationwide.
Source
FDA recall D-0525-2026 (report date 20260520)
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (908 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to June 2, 2026.
Frequently Asked Questions
Common questions about this FDA recall.